DMARD-free remission as novel treatment target in rheumatoid arthritis: A systematic literature review of achievability and sustainability

OBJECTIVES: Although current treatment guidelines for rheumatoid arthritis (RA) suggest tapering disease-modifying anti-rheumatic drugs (DMARDs), it is unclear whether DMARD-free remission (DFR) is an achievable and sustainable outcome. Therefore, we systematically reviewed the literature to determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Verstappen, M, van Mulligen, E, de Jong, P H P, van der Helm-Van Mil, A H M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299506/
https://www.ncbi.nlm.nih.gov/pubmed/32393523
http://dx.doi.org/10.1136/rmdopen-2020-001220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299506/
https://www.ncbi.nlm.nih.gov/pubmed/32393523
http://dx.doi.org/10.1136/rmdopen-2020-001220

Ejemplares similares